Press release
Sales of Deep Brain Stimulation Devices Market Analysis and Outlook Report 2028
Deep Brain Stimulation Devices Market
The global deep brain stimulation devices market for Parkinson's disease was valued at US$ 0.85 Bn in 2020
It is estimated to expand at a CAGR of 5.1% from 2021 to 2028
The global deep brain stimulation devices market for Parkinson's disease is expected to surpass the value of US$ 1.2 Bn by the end of 2028
Report Overview: https://www.transparencymarketresearch.com/deep-brain-stimulator-market.html
Increase in Government Initiatives: Key Driver
Surge in the geriatric population and rise in demand for minimally invasive surgical techniques fuel the growth of the global market. Moreover, change in preferences of patients and healthcare professionals to adopt surgical DBS devices over drug therapy is projected to fuel the expansion of the global DBS devices market in the near future. This is due to considerable side effects and loss of effectiveness of drug and other therapies. This is anticipated to drive the DBS devices market for Parkinson's disease over the next few years.
Increase in the number of neurological disorders such ischemic stroke, Alzheimer's disease, essential tremors, trauma, and Parkinson's disease (PD) is a primary factor boosting the growth of the global deep brain stimulation devices market.
North America to Dominate Deep Brain Stimulation Devices Market for Parkinson 's disease
Based on product type, the global deep brain stimulation devices market for Parkinson's disease has been segmented into single-channel deep brain stimulator, and dual-channel deep brain stimulator. In terms of end-user, the global deep brain stimulation devices market for Parkinson's disease has been classified into hospitals, ambulatory surgical centers, neurological clinics, and others.
The global deep brain stimulation devices market for Parkinson's disease has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global market during the forecast period, accounting for 38.60% share by 2028. The market in the region is anticipated to reach US$ 0.48 Bn by 2028.
Get Sample Copy of the Report@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1435
North America's largest market share can be attributed to increase in the number of patients undergoing surgical therapy that utilizes DBS devices for treating Parkinson's disease and surge in geriatric population. Additionally, favorable government reimbursement policies and the risk of side effects related to medication treatments are expected to fuel the growth of the market in the region.
Major Players
Major players operating in the global deep brain stimulation devices market are Medtronic, Inc., St. Jude Medical, Inc., and Boston Scientific Corporation. These companies have commercialized several significant DBS devices in the global market such as Libra, Activa, Vercise and others. Other companies active in the market include Aleva Neurotherapeutics SA, Adaptive Neuromodulation GmbH (ANM), NeuroSigma, Inc. and NeuroPace, Inc. DBS products of these players are not yet commercially available in the market, as these are still under clinical trial. Companies focus on introducing innovative products that are easy to use for physicians as well as patients. These companies aim to make the devices more portable, affordable, efficient, and effective.
Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=1435
Each of these players has been profiled in the deep brain stimulation devices market for Parkinson's disease report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments.
Global Deep Brain Stimulation Devices Market for Parkinson 's disease: Segmentation
Deep Brain Stimulation Devices Market for Parkinson's Disease, by Product Type
Single-Channel Deep Brain Stimulator
Dual-Channel Deep Brain Stimulator
Deep Brain Stimulation Devices Market for Parkinson's Disease, by End-user
Hospitals
Ambulatory Surgical Centers
Neurological Clinics
Others
Request Report Methodology: https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=1435
Deep Brain Stimulation Devices Market for Parkinson's Disease, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East & Africa
About Us
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: 1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Sales of Deep Brain Stimulation Devices Market Analysis and Outlook Report 2028 here
News-ID: 2789946 • Views: …
More Releases from Transparency Market Research
Isononanoic Acid Market Outlook 2034: Global Industry to Reach US$ 651.2 Million …
The global isononanoic acid market is entering a phase of steady expansion, supported by rising demand across lubricants, personal care formulations, metalworking fluids, plasticizers, and specialty chemical applications. Valued at US$ 346.4 million in 2023, the market is projected to expand at a CAGR of 5.2% between 2024 and 2034, reaching an estimated US$ 651.2 million by 2034. The outlook remains positive as manufacturers increasingly adopt high-performance, low-volatility, and environmentally…
Baby Car Seat Market Outlook 2034: Safety Mandates, Innovation, and Rising Paren …
The global baby car seat market is entering a phase of steady and sustainable expansion, propelled by heightened parental awareness, stringent vehicle safety regulations, and continuous technological innovations in child mobility products. Valued at US$ 4.9 Bn in 2023, the market is projected to grow at a CAGR of 4.9% during 2024-2034, ultimately reaching US$ 8.2 Bn by 2034. This growth trajectory reflects not only rising birth rates in certain…
FPSO Pump Market Outlook 2034: Global Industry Set to Reach US$ 5.9 Billion with …
The FPSO (Floating Production, Storage, and Offloading) pump market is entering a phase of robust expansion as offshore oil and gas exploration accelerates across deepwater and ultra-deepwater fields. Valued at US$ 1.9 billion in 2023, the market is projected to grow at an impressive CAGR of 11.2% from 2024 to 2034, ultimately reaching US$ 5.9 billion by 2034. Rising global energy demand, increased offshore investments, and the strategic shift toward…
Elemental Phosphorus (P4) and Derivatives Market to Reach US$ 4.6 Billion by 203 …
The Elemental Phosphorus (P4) and Derivatives Market was valued at US$ 2.5 billion in 2023 and is forecast to grow at a CAGR of 5.7% from 2024 to 2034, reaching an estimated US$ 9.6 billion by 2034. Growth is fueled by rising demand for phosphorus derivatives such as phosphoric acid, phosphorus trichloride, and phosphorus pentoxide across fertilizers, industrial chemicals, flame retardants, and advanced energy storage applications.
Elemental phosphorus is produced primarily…
More Releases for Parkinson
Key Trends Reshaping the Wolff Parkinson White Syndrome Market: Technological Ad …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Wolff Parkinson White Syndrome Market Size Growth Forecast: What to Expect by 2025?
The market for Wolff Parkinson White syndrome has registered consistent growth over the recent past. The expectation is that it will expand from $1.17 billion in 2024 to $1.22 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.5%.…
Evolving Market Trends In The Anti-Parkinson Drugs Industry: Innovative Advancem …
The Anti-Parkinson Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Anti-Parkinson Drugs Market Size During the Forecast Period?
The anti-parkinson drugs market has seen significant growth in recent years, projected to increase from $10.37 billion in 2024 to $11.08 billion in…
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market?
In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced…
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market?
In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced…
Wolff Parkinson White Syndrome Treatment Market Overview 2024-2033
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Wolff Parkinson White Syndrome Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $1.43 billion…
Anti-Parkinson Drugs Market Overview
Exhibiting robust growth, the anti-parkinson drugs market is set to escalate from $9.73 billion in 2023 to $10.43 billion in 2024, with a notable Compound Annual Growth Rate (CAGR) of 7.2%. The trajectory continues on an upward trend, with an anticipated market size of $13.36 billion by 2028, sustaining a robust CAGR of 6.4%.
Increasing Geriatric Population Driving Demand:
The burgeoning geriatric population, coupled with a surge in Parkinson's disease cases,…
